Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India - Authors' reply.

Thiruvengadam, Ramachandran; Awasthi, Amit; Bhatnagar, Shinjini; Garg, Pramod Kumar

Thiruvengadam, Ramachandran; Awasthi, Amit; Bhatnagar, Shinjini; Garg, Pramod Kumar.

Thiruvengadam R; Translational Health Science and Technology Institute, Faridabad 121001, India.
Awasthi A; Translational Health Science and Technology Institute, Faridabad 121001, India.
Bhatnagar S; Translational Health Science and Technology Institute, Faridabad 121001, India.
Garg PK; Translational Health Science and Technology Institute, Faridabad 121001, India. Electronic address: pgarg@thsti.res.in.

Lancet Infect Dis ; 22(4): 447, 2022 04.

Article in English | MEDLINE | ID: covidwho-1757991

Subject(s)

ChAdOx1 nCoV-19; Humans; India/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: ChAdOx1 nCoV-19 Type of study: Experimental Studies / Observational study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Asia Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S1473-3099(22)00120-7

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google